Le Lézard
Classified in: Health, Science and technology
Subject: CCA

Infinity Announces the Date of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast



CAMBRIDGE, Mass., March 8, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Thursday, March 15, 2018, at 4:30 p.m. ET to review its fourth quarter and full year 2017 financial results and provide an update on the company.

A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 5558799. An archived version of the webcast will be available on Infinity's website for 30 days.

About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:
Stephanie Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com

SOURCE Infinity Pharmaceuticals, Inc.


These press releases may also interest you

at 16:30
The "Global Medical Coding Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global Medical Coding Market is poised to grow strong during the forecast period 2017 to 2027 Some of...

at 16:27
The board of directors of Eli Lilly and Company has declared a dividend for the third quarter of 2018 of $0.5625 per share on outstanding common stock. The dividend is payable September 10, 2018, to shareholders of record at the close of business...

at 16:05
Myovant Sciences , a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women's health and endocrine diseases, today announced that Lynn Seely, M.D., President and Chief Executive Officer of...

at 16:00
The "Global Nutraceutical Excipients Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global Nutraceutical Excipients Market is poised to grow strong during the forecast period...

at 15:56
PDI, a leader in infection prevention products and solutions, today hosted its seventh-annual Be the Difference® Day, a company-wide celebration of local community service, at its headquarters in Orangeburg, N.Y. Rockland County officials formally...

at 15:45
BOCA RATON, Fla., June 18, 2018 /PRNewswire-PRWeb/ -- Sage Dental Management today announced Thomas Marler has been appointed the new President and Chief Executive Officer effective immediately. Marler, a seasoned executive with over 16 years'...




News published on 8 march 2018 at 16:05 and distributed by: